Clinical Trial Update: To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating serplulimab in combination with carboplatin and etoposide for efficacy and safety in US patients with extensive-stage small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Serplulimab (serplulimab)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING